Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 302

1.

The golden age for patients in their golden years: The progressive upheaval of age and the treatment of newly-diagnosed acute myeloid leukemia.

Shallis RM, Boddu PC, Bewersdorf JP, Zeidan AM.

Blood Rev. 2019 Nov 8:100639. doi: 10.1016/j.blre.2019.100639. [Epub ahead of print] Review.

PMID:
31761380
2.

Barriers to Accessing Acute Care for Newly Arrived Refugees.

Zeidan AJ, Khatri UG, Munyikwa M, Barden A, Samuels-Kalow M.

West J Emerg Med. 2019 Oct 16;20(6):842-850. doi: 10.5811/westjem.2019.8.43129.

3.

Cricoid Pressure: Do No Harm, But Do It Correctly.

Khorasani A, Salem MR, Zeidan A, Al-Faraj A.

Anesth Analg. 2019 Nov 5. doi: 10.1213/ANE.0000000000004523. [Epub ahead of print] No abstract available.

PMID:
31702695
4.

Physician Experience and Risk of Rituximab Discontinuation in Older Adults With Non-Hodgkin's Lymphoma.

Huntington SF, Hoag JR, Wang R, Zeidan AM, Giri S, Gore SD, Ma X, Gross CP, Davidoff AJ.

J Natl Compr Canc Netw. 2019 Oct 1;17(10):1194-1202. doi: 10.6004/jnccn.2019.7314.

PMID:
31590152
5.

Association of provider experience and clinical outcomes in patients with myelodysplastic syndromes receiving hypomethylating agents.

Zeidan AM, Hu X, Zhu W, Stahl M, Wang R, Huntington SF, Giri S, Bewersdorf JP, Podoltsev NA, Gore SD, Ma X, Davidoff AJ.

Leuk Lymphoma. 2019 Oct 1:1-12. doi: 10.1080/10428194.2019.1663423. [Epub ahead of print]

PMID:
31570040
6.

Temporal patterns and predictors of receiving no active treatment among older patients with acute myeloid leukemia in the United States: A population-level analysis.

Zeidan AM, Podoltsev NA, Wang X, Bewersdorf JP, Shallis RM, Huntington SF, Gore SD, Davidoff AJ, Ma X, Wang R.

Cancer. 2019 Dec 1;125(23):4241-4251. doi: 10.1002/cncr.32439. Epub 2019 Sep 4.

PMID:
31483484
7.

#Shemergency: Use of a Professional Development Group to Promote Female Resident Recruitment and Retention.

Khatri UG, Love J, Zeidan A, Hsu CH, Mills AM.

Acad Med. 2019 Aug 27. doi: 10.1097/ACM.0000000000002969. [Epub ahead of print]

PMID:
31464733
8.

Adductor Canal Block: A Synthesis of the Evidence?

Zeidan A.

Anesth Analg. 2019 Sep;129(3):e105-e106. doi: 10.1213/ANE.0000000000004279. No abstract available.

PMID:
31425242
9.

Hedgehog pathway inhibition as a therapeutic target in acute myeloid leukemia.

Shallis RM, Bewersdorf JP, Boddu PC, Zeidan AM.

Expert Rev Anticancer Ther. 2019 Aug;19(8):717-729. doi: 10.1080/14737140.2019.1652095. Epub 2019 Aug 17.

PMID:
31422721
10.

From clonal hematopoiesis to myeloid leukemia and what happens in between: Will improved understanding lead to new therapeutic and preventive opportunities?

Bewersdorf JP, Ardasheva A, Podoltsev NA, Singh A, Biancon G, Halene S, Zeidan AM.

Blood Rev. 2019 Sep;37:100587. doi: 10.1016/j.blre.2019.100587. Epub 2019 Jul 4. Review.

PMID:
31400824
11.

Underutilization of guideline-recommended supportive care among older adults with multiple myeloma in the United States.

Giri S, Zhu W, Wang R, Zeidan A, Podoltsev N, Gore SD, Neparidze N, Ma X, Gross CP, Davidoff AJ, Huntington SF.

Cancer. 2019 Nov 15;125(22):4084-4095. doi: 10.1002/cncr.32428. Epub 2019 Aug 5.

PMID:
31381151
12.

Association Between Ownership of Imaging Equipment and Appropriateness of Staging Positron-Emission Tomography in Non-Hodgkin Lymphoma.

Huntington SF, Zhu W, Hoag JR, Wang R, Zeidan AM, Giri S, Podoltsev NA, Gore SD, Ma X, Gross CP, Davidoff AJ.

JNCI Cancer Spectr. 2019 May 11;3(2):pkz030. doi: 10.1093/jncics/pkz030. eCollection 2019 Jun.

13.

The Role of Protein Tyrosine Phosphatase (PTP)-1B in Cardiovascular Disease and Its Interplay with Insulin Resistance.

Abdelsalam SS, Korashy HM, Zeidan A, Agouni A.

Biomolecules. 2019 Jul 17;9(7). pii: E286. doi: 10.3390/biom9070286. Review.

14.

Asylum Medicine: Standard and Best Practices.

Ferdowsian H, McKenzie K, Zeidan A.

Health Hum Rights. 2019 Jun;21(1):215-225.

16.

RBC transfusion independence among lower risk MDS patients receiving hypomethylating agents: a population-level analysis.

Zeidan AM, Zhu W, Stahl M, Wang R, Huntington SF, Giri S, Podoltsev NA, Gore SD, Ma X, Davidoff AJ.

Leuk Lymphoma. 2019 Jun 7:1-7. doi: 10.1080/10428194.2019.1622700. [Epub ahead of print]

PMID:
31170846
17.

Healthcare expenses for treatment of acute myeloid leukemia.

Bewersdorf JP, Shallis RM, Wang R, Huntington SF, Perreault S, Ma X, Zeidan AM.

Expert Rev Hematol. 2019 Aug;12(8):641-650. doi: 10.1080/17474086.2019.1627869. Epub 2019 Jun 13.

PMID:
31159602
18.

A comparative genomics approach for identifying host-range determinants in Streptococcus thermophilus bacteriophages.

Szymczak P, Rau MH, Monteiro JM, Pinho MG, Filipe SR, Vogensen FK, Zeidan AA, Janzen T.

Sci Rep. 2019 May 29;9(1):7991. doi: 10.1038/s41598-019-44481-z.

19.

A possible association between statin use and improved Clostridioides difficile infection mortality in veterans.

Argamany JR, Lee GC, Duhon BD, Zeidan AR, Young EH, Reveles KR.

PLoS One. 2019 May 28;14(5):e0217423. doi: 10.1371/journal.pone.0217423. eCollection 2019.

20.

High-Resolution, Wide-Field, Forward-Viewing Spectrally Encoded Endoscope.

Zeidan A, Do D, Kang D, Ikuta M, Ryu J, Tearney GJ.

Lasers Surg Med. 2019 Nov;51(9):808-814. doi: 10.1002/lsm.23102. Epub 2019 May 26.

PMID:
31129921
21.

Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges.

Shallis RM, Wang R, Davidoff A, Ma X, Zeidan AM.

Blood Rev. 2019 Jul;36:70-87. doi: 10.1016/j.blre.2019.04.005. Epub 2019 Apr 29. Review.

PMID:
31101526
22.

Use of Immunosuppressive therapy for management of myelodysplastic syndromes: a systematic review and meta-analysis.

Stahl M, Bewersdorf JP, Giri S, Wang R, Zeidan AM.

Haematologica. 2019 Apr 19. pii: haematol.2019.219345. doi: 10.3324/haematol.2019.219345. [Epub ahead of print]

23.

Activation of Kv7 channels with the anticonvulsant retigabine alleviates neuropathic pain behaviour in the streptozotocin rat model of diabetic neuropathy.

Djouhri L, Malki MI, Zeidan A, Nagi K, Smith T.

J Drug Target. 2019 Dec;27(10):1118-1126. doi: 10.1080/1061186X.2019.1608552. Epub 2019 May 6.

PMID:
30995134
24.

Endoplasmic Reticulum Stress: A Critical Molecular Driver of Endothelial Dysfunction and Cardiovascular Disturbances Associated with Diabetes.

Maamoun H, Abdelsalam SS, Zeidan A, Korashy HM, Agouni A.

Int J Mol Sci. 2019 Apr 3;20(7). pii: E1658. doi: 10.3390/ijms20071658. Review.

25.

Getting personal with myelodysplastic syndromes: is now the right time?

Chokr N, Pine AB, Bewersdorf JP, Shallis RM, Stahl M, Zeidan AM.

Expert Rev Hematol. 2019 Apr;12(4):215-224. doi: 10.1080/17474086.2019.1592673. Epub 2019 Apr 12.

PMID:
30977414
26.

Transforming growth factor (TGF)-β pathway as a therapeutic target in lower risk myelodysplastic syndromes.

Bewersdorf JP, Zeidan AM.

Leukemia. 2019 Jun;33(6):1303-1312. doi: 10.1038/s41375-019-0448-2. Epub 2019 Apr 8. Review.

PMID:
30962581
27.

Allogeneic stem cell transplantation and combination antiretroviral therapy: cautions, complications, and considerations.

Shallis RM, Gleeson S, Azar MM, Malinis M, Xu ML, Seropian SE, Gowda L, Zeidan AM.

Leuk Lymphoma. 2019 Oct;60(10):2584-2587. doi: 10.1080/10428194.2019.1594221. Epub 2019 Apr 3. No abstract available.

PMID:
30943051
28.

Myeloid disorders after autoimmune disease.

Boddu PC, Zeidan AM.

Best Pract Res Clin Haematol. 2019 Mar;32(1):74-88. doi: 10.1016/j.beha.2019.02.002. Epub 2019 Feb 7. Review.

PMID:
30927978
29.

Immune checkpoint-based therapy in myeloid malignancies: a promise yet to be fulfilled.

Bewersdorf JP, Stahl M, Zeidan AM.

Expert Rev Anticancer Ther. 2019 May;19(5):393-404. doi: 10.1080/14737140.2019.1589374. Epub 2019 Mar 19.

PMID:
30887841
30.

Impact of Hydroxyurea on Survival and Risk of Thrombosis Among Older Patients With Essential Thrombocythemia.

Podoltsev NA, Zhu M, Zeidan AM, Wang R, Wang X, Davidoff AJ, Huntington SF, Giri S, Gore SD, Ma X.

J Natl Compr Canc Netw. 2019 Mar 1;17(3):211-219. doi: 10.6004/jnccn.2018.7095.

PMID:
30865915
31.

Will deeper characterization of the landscape of immune checkpoint molecules in acute myeloid leukemia bone marrow lead to improved therapeutic targeting?

Vandsemb EN, Kim TK, Zeidan AM.

Cancer. 2019 May 1;125(9):1410-1413. doi: 10.1002/cncr.32042. Epub 2019 Mar 12. No abstract available.

PMID:
30861094
32.

Better understanding of the effectiveness of cricoid pressure and the rapid sequence induction.

Zeidan A, Al-Zaher Z, Bamadhaj M, Salem MR, Khorasani A.

Acta Anaesthesiol Scand. 2019 Jul;63(6):837-838. doi: 10.1111/aas.13348. Epub 2019 Mar 12. No abstract available.

PMID:
30860296
33.

Evaluation of out-of-hospital cardiac arrest using transesophageal echocardiography in the emergency department.

Teran F, Dean AJ, Centeno C, Panebianco NL, Zeidan AJ, Chan W, Abella BS.

Resuscitation. 2019 Apr;137:140-147. doi: 10.1016/j.resuscitation.2019.02.013. Epub 2019 Feb 16.

PMID:
30779977
34.

Epigenetic therapy combinations in acute myeloid leukemia: what are the options?

Bewersdorf JP, Shallis R, Stahl M, Zeidan AM.

Ther Adv Hematol. 2019 Jan 11;10:2040620718816698. doi: 10.1177/2040620718816698. eCollection 2019. Review.

35.

Implicit Bias Education and Emergency Medicine Training: Step One? Awareness.

Zeidan AJ, Khatri UG, Aysola J, Shofer FS, Mamtani M, Scott KR, Conlon LW, Lopez BL.

AEM Educ Train. 2018 Sep 24;3(1):81-85. doi: 10.1002/aet2.10124. eCollection 2019 Jan.

36.

Are we witnessing the start of a therapeutic revolution in acute myeloid leukemia?

Bewersdorf JP, Stahl M, Zeidan AM.

Leuk Lymphoma. 2019 Jun;60(6):1354-1369. doi: 10.1080/10428194.2018.1546854. Epub 2019 Jan 17.

PMID:
30652518
37.

Putative antibiotic resistance genes present in extant Bacillus licheniformis and Bacillus paralicheniformis strains are probably intrinsic and part of the ancient resistome.

Agersø Y, Bjerre K, Brockmann E, Johansen E, Nielsen B, Siezen R, Stuer-Lauridsen B, Wels M, Zeidan AA.

PLoS One. 2019 Jan 15;14(1):e0210363. doi: 10.1371/journal.pone.0210363. eCollection 2019.

38.

Treatment sequence of lenalidomide and hypomethylating agents and the impact on clinical outcomes for patients with myelodysplastic syndromes.

Zeidan AM, Klink AJ, McGuire M, Feinberg B.

Leuk Lymphoma. 2019 Aug;60(8):2050-2055. doi: 10.1080/10428194.2018.1551538. Epub 2019 Jan 14.

PMID:
30636526
39.

Immunotherapy in acute myeloid leukemia and myelodysplastic syndromes: The dawn of a new era?

Liu Y, Bewersdorf JP, Stahl M, Zeidan AM.

Blood Rev. 2019 Mar;34:67-83. doi: 10.1016/j.blre.2018.12.001. Epub 2018 Dec 5. Review.

PMID:
30553527
40.

Impact of selenium nano-particles in semen extender on bull sperm quality after cryopreservation.

Khalil WA, El-Harairy MA, Zeidan AEB, Hassan MAE.

Theriogenology. 2019 Mar 1;126:121-127. doi: 10.1016/j.theriogenology.2018.12.017. Epub 2018 Dec 5.

PMID:
30551018
41.

Surface anatomical landmarks or ultrasound for cricoid pressure application.

Zeidan A, Ramez Salem M, Khorasani A.

Anaesthesia. 2019 Jan;74(1):121. doi: 10.1111/anae.14522. No abstract available.

PMID:
30511751
42.

Water-pipe smoking promotes epithelial-mesenchymal transition and invasion of human breast cancer cells via ERK1/ERK2 pathways.

Sadek KW, Haik MY, Ashour AA, Baloch T, Aboulkassim T, Yasmeen A, Vranic S, Zeidan A, Al Moustafa AE.

Cancer Cell Int. 2018 Nov 13;18:180. doi: 10.1186/s12935-018-0678-9. eCollection 2018.

43.

Systematic review and meta-analysis of the effect of iron chelation therapy on overall survival and disease progression in patients with lower-risk myelodysplastic syndromes.

Zeidan AM, Giri S, DeVeaux M, Ballas SK, Duong VH.

Ann Hematol. 2019 Feb;98(2):339-350. doi: 10.1007/s00277-018-3539-7. Epub 2018 Nov 9.

PMID:
30413901
44.

The impact of phlebotomy and hydroxyurea on survival and risk of thrombosis among older patients with polycythemia vera.

Podoltsev NA, Zhu M, Zeidan AM, Wang R, Wang X, Davidoff AJ, Huntington SF, Giri S, Gore SD, Ma X.

Blood Adv. 2018 Oct 23;2(20):2681-2690. doi: 10.1182/bloodadvances.2018021436.

45.

Epidemiology of myelodysplastic syndromes: Why characterizing the beast is a prerequisite to taming it.

Zeidan AM, Shallis RM, Wang R, Davidoff A, Ma X.

Blood Rev. 2019 Mar;34:1-15. doi: 10.1016/j.blre.2018.09.001. Epub 2018 Sep 21. Review.

PMID:
30314642
46.

Oncologist volume and outcomes in older adults diagnosed with diffuse large B cell lymphoma.

Huntington SF, Hoag JR, Zhu W, Wang R, Zeidan AM, Giri S, Podoltsev NA, Gore SD, Ma X, Gross CP, Davidoff AJ.

Cancer. 2018 Nov 1;124(21):4211-4220. doi: 10.1002/cncr.31688. Epub 2018 Sep 14.

47.

Trainability of Application of the Correct Cricoid Force: Time to Rely on Devices?

Salem MR, Khorasani A, Al-Zaher Z, Bamadhaj M, Zeidan A.

Anesth Analg. 2019 Feb;128(2):e29. doi: 10.1213/ANE.0000000000003777. No abstract available.

PMID:
30211775
48.

Be careful of the masquerades: differentiating secondary myelodysplasia from myelodysplastic syndromes in clinical practice.

Shallis RM, Xu ML, Podoltsev NA, Curtis SA, Considine BT, Khanna SR, Siddon AJ, Zeidan AM.

Ann Hematol. 2018 Dec;97(12):2333-2343. doi: 10.1007/s00277-018-3474-7. Epub 2018 Aug 14.

PMID:
30109425
49.

Conviction in the face of affliction: a case series of Jehovah's Witnesses with myeloid malignancies.

Shallis RM, Xu ML, Curtis SA, Medoff E, Mixon R, Folkers A, Zeidan AM.

Ann Hematol. 2018 Nov;97(11):2245-2248. doi: 10.1007/s00277-018-3459-6. Epub 2018 Aug 7. Review. No abstract available.

PMID:
30088044
50.

Aplastic anemia: Etiology, molecular pathogenesis, and emerging concepts.

Shallis RM, Ahmad R, Zeidan AM.

Eur J Haematol. 2018 Dec;101(6):711-720. doi: 10.1111/ejh.13153. Epub 2018 Oct 10. Review.

PMID:
30055055

Supplemental Content

Loading ...
Support Center